EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

Jyotirmayee Talapatra iD, Mamatha M Reddy iD

Cancers · 04.04.2023 · 15 (7) · 2144

DOI: 10.3390/cancers15072144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.04.2023. Verfasst von Jyotirmayee Talapatra und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar 751024, India. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor cells reprogram their metabolism, including glucose, glutamine, nucleotide, lipid, and amino acids to meet their enhanced energy demands, redox balance, and requirement of biosynthetic substrates for uncontrolled cell proliferation. Altered lipid metabolism in cancer provides lipids for rapid membrane biogenesis, generates the energy required for unrestricted cell proliferation, and some of the lipids act as signaling pathway mediators. In this review, we focus on the role of lipid metabolism in embryonal neoplasms with MYCN dysregulation. We specifically review lipid metabolic reactions in neuroblastoma, retinoblastoma, medulloblastoma, Wilms tumor, and rhabdomyosarcoma and the possibility of targeting lipid metabolism. Additionally, the regulation of lipid metabolism by the MYCN oncogene is discussed.

Schlagwörter

Stichwörter der Autor:innen

MYCNcancerembryonal tumorslipid metabolismtherapeutic targeting

Autor:innen und Institutionen

  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Bhubaneswar 751024, India.
  • School of Biotechnology, KIIT Deemed to Be University, Bhubaneswar 751024, India.

ORCID-Profile: Jyotirmayee Talapatra, Mamatha M Reddy

Förderung

  • Department of Biotechnology
  • Indian Council of Medical Research

Zitieren

APA

Talapatra, J., & Reddy, M. M. (2023). Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. Cancers, 15(7), 2144. https://doi.org/10.3390/cancers15072144

Vancouver

Talapatra J, Reddy MM. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. Cancers. 2023;15(7):2144. doi:10.3390/cancers15072144

BibTeX
@article{Talapatra2023,
  author = {Talapatra, Jyotirmayee and Reddy, Mamatha M},
  title = {Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {2144},
  doi = {10.3390/cancers15072144}
}
Kostenlos starten →